000 01784 a2200445 4500
005 20250515052147.0
264 0 _c20080109
008 200801s 0 0 eng d
022 _a0167-6806
024 7 _a10.1007/s10549-006-9459-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHodges-Gallagher, Leslie
245 0 0 _aInhibition of histone deacetylase enhances the anti-proliferative action of antiestrogens on breast cancer cells and blocks tamoxifen-induced proliferation of uterine cells.
_h[electronic resource]
260 _bBreast cancer research and treatment
_cNov 2007
300 _a297-309 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAromatase
_xmetabolism
650 0 4 _aBreast Neoplasms
_xmetabolism
650 0 4 _aCell Line
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aEstrogen Antagonists
_xpharmacology
650 0 4 _aEstrogen Receptor alpha
_xgenetics
650 0 4 _aEstrogens
_xmetabolism
650 0 4 _aFemale
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aHistone Deacetylase Inhibitors
650 0 4 _aHistone Deacetylases
_xmetabolism
650 0 4 _aHumans
650 0 4 _aReceptor, ErbB-2
_xmetabolism
650 0 4 _aSensitivity and Specificity
650 0 4 _aTamoxifen
_xantagonists & inhibitors
650 0 4 _aUterus
_xcytology
650 0 4 _aValproic Acid
_xpharmacology
700 1 _aValentine, Cathleen D
700 1 _aBader, Suzy El
700 1 _aKushner, Peter J
773 0 _tBreast cancer research and treatment
_gvol. 105
_gno. 3
_gp. 297-309
856 4 0 _uhttps://doi.org/10.1007/s10549-006-9459-6
_zAvailable from publisher's website
999 _c16753773
_d16753773